Found 3 projects
Oral Presentation 1
11:30 AM to 1:00 PM
- Presenter
-
- Vrishab Sathish Kumar, Senior, Computer Science Mary Gates Scholar, Washington Research Foundation Fellow
- Mentors
-
- David Beck, Chemical Engineering
- Mary Lidstrom, Chemical Engineering, Microbiology
- Erin Wilson, Computer Science & Engineering
- Session
-
-
Session O-1M: Computing & Machine Learning
- MGH 238
- 11:30 AM to 1:00 PM
Methanotrophs are prokaryotes that naturally consume the potent greenhouse gas methane for energy. Through metabolic engineering at an industrial scale, these microorganisms hold potential to mitigate the contribution of methane emissions to global warming. In particular, Methylotuvimicrobium buryatense can sustain robust growth both in nature and experimental settings; it is a promising engineering candidate. To develop a robust metabolic engineering platform using M. buryatense, biologists require a deeper understanding of the genetic mechanisms by which it functions. Here, I present an open-source software tool designed to interactively explore the transcriptome of M. buryatense. By integrating bulk RNA-seq datasets collected from experiments over the past decade and applying an array of unsupervised machine learning clustering algorithms, we cluster genes by their expression profiles in differing growth conditions. These gene clusters are annotated with gene ontology (GO) terms using statistical enrichment analysis to assist in functional interpretation of the clusters and the genes that comprise them. To enhance domain-expert researchers’ ability to explore and drill-down into specific queries, I unify these cluster-specific analyses in a web-hosted tool using interactive data visualization techniques centered on a ReactJS frontend and Azure Cloud backend. With both exploratory and query-focused use cases, this software tool can support M. buryatense biologist workflows for predicting functions of hypothetical proteins, showcase new or confirming putative regulatory processes, and generate new experimental hypotheses from the presented transcriptomic trends.
Poster Presentation 2
12:45 PM to 2:00 PM
- Presenter
-
- Naomi Elizabeth (Naomi) Kern, Senior, Chemical Engineering Mary Gates Scholar
- Mentor
-
- Mary Lidstrom, Chemical Engineering, Microbiology
- Session
-
-
Poster Session 2
- 3rd Floor
- Easel #107
- 12:45 PM to 2:00 PM
Poster Presentation 4
3:45 PM to 5:00 PM
- Presenters
-
- Thy Nguyen Minh (Thy Le) Le, Senior, Biology (Molecular, Cellular & Developmental)
- Zoe Moon, Junior, Biology (Molecular, Cellular & Developmental)
- Mentor
-
- Mary Beth Brown, Rehabilitation Medicine
- Session
-
-
Poster Session 4
- Balcony
- Easel #55
- 3:45 PM to 5:00 PM
Duchenne Muscular Dystrophy (DMD) is a severe muscle wasting disease caused by deficiency of the protein dystrophy and affects approximately 1/3500 boys. Patients have shortened life expectancy due to cardio-respiratory problems caused by the disease alongside impaired ambulatory function. Previous studies have described the “waddling” gait in patients with muscular dystrophy but not in the animal model of DMD. Here we present the characterization of exercise ability and quantified gait metrics in a novel DMDmdx model that better represents DMD in humans. We used the Noldus Catwalk XT motion capture system to identify different gait parameters between DMDmdx and wild-type rats at 14-15 weeks of age. Compared to wild-type rats, DMDmdx has a reduced stride length and swing time in both front paws and hind paws. Time to max contact in DMDmdx rats is 5% faster than wild-type, but max intensity at time of max paw contact is 15% lower in DMDmdx. The “waddling” gait is indicated by 13% higher uses of 3 and 4 paws supported by DMDmdx during a run compared to wild-type. Subsequently, this led to a higher abnormal step pattern as similarly observed in patients with muscular dystrophy due to hip muscle weakness, thus resulting in the “waddling” gait. Gait pattern of the novel DMDmdx rat model reflects the impaired ambulatory function commonly seen in patients with DMD, thus making this a potentially useful outcome for understanding disease progression, therapies, and development of exercise guidelines.